Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03619811 · ClinicalTrials.gov registry record · NA

Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease

A NA study of Gastroesophageal Reflux and Laryngopharyngeal Reflux, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
43
Enrollment target
1
Study location

NCT03619811 is a NA study of Gastroesophageal Reflux and Laryngopharyngeal Reflux that has completed, run by University of California, San Diego. The registered enrollment target is 43 participants, below the 183-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03619811, a NA study of Gastroesophageal Reflux and Laryngopharyngeal Reflux, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about reflux associated laryngeal symptoms, and more efficient ways to diagnose and treat this condition.

Interventions

  • DIAGNOSTIC_TEST Reflux Band® Upper Esophageal Sphincter (UES) Assist Device

Study Locations (1)

California

  • University of California, San Diego - La Jolla

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2018-07-13
Est. Completion 2021-06-30
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT03619811

The ClinicalTrials.gov registry entry for NCT03619811 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 25 other Gastroesophageal Reflux trials with a reported enrollment target (77% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 1 intervention - of which Reflux Band® Upper Esophageal Sphincter (UES) Assist Device is the first listed.

NCT03619811 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03619811 about?

NCT03619811 is a clinical study titled "Precision Approach to PPI Therapy in Gastroesophageal Reflux Disease". This study plans to learn more about reflux associated laryngeal symptoms, and more efficient ways to diagnose and treat this condition.

What is the current status of trial NCT03619811?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2018-07-13. Estimated completion is 2021-06-30.

What conditions does trial NCT03619811 study?

This clinical trial studies the following conditions: Gastroesophageal Reflux, Laryngopharyngeal Reflux.

What interventions are being tested in trial NCT03619811?

The interventions under investigation include: Reflux Band® Upper Esophageal Sphincter (UES) Assist Device (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03619811?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03619811 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroesophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.